Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 832712, 9 pages
http://dx.doi.org/10.1155/2014/832712
Research Article

A Critical Role for ZDHHC2 in Metastasis and Recurrence in Human Hepatocellular Carcinoma

1Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang 310003, China
2Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China

Received 28 March 2014; Accepted 22 May 2014; Published 9 June 2014

Academic Editor: Youmin Wu

Copyright © 2014 Chuanhui Peng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. B. El-Serag and K. L. Rudolph, “Hepatocellular carcinoma: epidemiology and molecular carcinogenesis,” Gastroenterology, vol. 132, no. 7, pp. 2557–2576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Zhou, W. Zhou, L. Wu, X. Yu, C. Xing, and S. Zheng, “The association of frequent allelic loss on 17p13.1 with early metastastic recurrence of hepatocellular carcinoma after liver transplantation,” Journal of Surgical Oncology, vol. 102, no. 7, pp. 802–808, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Li, H. Wang, J. Li et al., “Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China,” Journal of Hepatology, vol. 34, no. 6, pp. 840–849, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Schwendel, H. Langreck, M. Reichel et al., “Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations,” International Journal of Cancer, vol. 74, no. 1, pp. 86–93, 1997. View at Google Scholar
  6. U. Bockmühl, S. Petersen, S. Schmidt et al., “Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas,” Cancer Research, vol. 57, no. 23, pp. 5213–5216, 1997. View at Google Scholar · View at Scopus
  7. T. Lu and H. Hano, “Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma,” Liver International, vol. 27, no. 6, pp. 782–790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Okuno, M. Ueda, T. Tsuruyama et al., “Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma,” Cancer Science, vol. 100, no. 3, pp. 520–528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Midorikawa, S. Yamamoto, S. Tsuji et al., “Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis,” Hepatology, vol. 49, no. 2, pp. 513–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. W. Chou, K. Chung, L. Jeng, T. Chen, and Y. Liaw, “Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan,” Cancer Letters, vol. 123, no. 1, pp. 1–6, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Emi, Y. Fujiwara, H. Ohata et al., “Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma,” Genes Chromosomes and Cancer, vol. 7, no. 3, pp. 152–157, 1993. View at Google Scholar · View at Scopus
  12. Y. Fujiwara, H. Ohata, M. Emi et al., “A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer,” Genes Chromosomes and Cancer, vol. 10, no. 1, pp. 7–14, 1994. View at Google Scholar · View at Scopus
  13. Y. Fujiwara, M. Emi, H. Ohata et al., “Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma,” Cancer Research, vol. 53, no. 5, pp. 1172–1174, 1993. View at Google Scholar · View at Scopus
  14. R. Anbazhagan, H. Fujii, and E. Gabrielson, “Allelic loss of chromosomal arm 8p in breast cancer progression,” The American Journal of Pathology, vol. 152, no. 3, pp. 815–819, 1998. View at Google Scholar · View at Scopus
  15. G. S. Bova, B. S. Carter, M. J. G. Bussemakers et al., “Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer,” Cancer Research, vol. 53, no. 17, pp. 3869–3873, 1993. View at Google Scholar · View at Scopus
  16. M. A. Knowles, M. E. Shaw, and A. J. Proctor, “Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms,” Oncogene, vol. 8, no. 5, pp. 1357–1364, 1993. View at Google Scholar · View at Scopus
  17. J. Pang, L. Qin, N. Ren et al., “Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma,” Clinical Cancer Research, vol. 13, no. 24, pp. 7363–7369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Funel, M. Morelli, E. Giovannetti et al., “Loss of heterozygosity status of d9s105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions,” Pancreatology, vol. 11, no. 1, pp. 30–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Zhang, L. Wu, L. Zhou et al., “Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation,” Annals of Surgical Oncology, vol. 15, no. 12, pp. 3494–3502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Cheng, L. Zhou, Q. Xie et al., “The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells,” Proteomics, vol. 10, no. 9, pp. 1557–1572, 2010. View at Google Scholar · View at Scopus
  21. L. Wu, Z. Yang, L. Zhou et al., “Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma,” PLoS ONE, vol. 5, no. 12, Article ID e14460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Zheng, X. Xu, J. Wu et al., “Liver transplantation for hepatocellular carcinoma: Hangzhou experiences,” Transplantation, vol. 85, no. 12, pp. 1726–1732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Zimmerman, R. M. Ghobrial, M. J. Tong et al., “Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators,” Archives of Surgery, vol. 143, no. 2, pp. 182–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Lu, H. Hano, C. Meng, K. Nagatsuma, S. Chiba, and M. Ikegami, “Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 13, no. 7, pp. 1090–1097, 2007. View at Google Scholar · View at Scopus
  25. T. J. Seng, J. S. W. Low, H. Li et al., “The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation,” Oncogene, vol. 26, no. 6, pp. 934–944, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Rodrigues-Ferreira, A. Di Tommasso, A. Dimitrov et al., “8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis,” PLoS ONE, vol. 4, no. 10, Article ID e7239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Oyama, Y. Miyoshi, K. Koyama et al., “Isolation of a novel gene on 8p21. 3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis,” Genes, Chromosomes and Cancer, vol. 29, no. 1, pp. 9–15, 2000. View at Google Scholar
  28. S. Yan, J. Tang, C. Huang et al., “Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinoma,” PLoS ONE, vol. 8, no. 2, Article ID e56366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Greaves and L. H. Chamberlain, “DHHC palmitoyl transferases: substrate interactions and (patho)physiology,” Trends in Biochemical Sciences, vol. 36, no. 5, pp. 245–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Zhang, S. L. Planey, C. Ceballos, S. M. Stevens Jr., S. K. Keay, and D. A. Zacharias, “Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method,” Molecular and Cellular Proteomics, vol. 7, no. 7, pp. 1378–1388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. L. Planey, S. K. Keay, C. Zhang, and D. A. Zacharias, “Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling,” Molecular Biology of the Cell, vol. 20, no. 5, pp. 1454–1463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Sharma, X. H. Yang, and M. E. Hemler, “DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151,” Molecular Biology of the Cell, vol. 19, no. 8, pp. 3415–3425, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Miyake, H. Inufusa, M. Adachi et al., “Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery,” Oncogene, vol. 19, no. 46, pp. 5221–5226, 2000. View at Google Scholar · View at Scopus
  34. M. Zöller, “Gastrointestinal tumors: metastasis and tetraspanins,” Zeitschrift fur Gastroenterologie, vol. 44, no. 7, pp. 573–586, 2006. View at Publisher · View at Google Scholar · View at Scopus